George Miljanich
Gründer bei SiteOne Therapeutics, Inc.
Profil
George Miljanich is the founder and Chief Scientific Officer of SiteOne Therapeutics, Inc. which is founded in 2010.
He is currently the Chief Executive Officer at Airmid, Inc. Dr. Miljanich has an undergraduate degree from the University of California, Berkeley and a doctorate from the University of California, Santa Cruz.
Aktive Positionen von George Miljanich
| Unternehmen | Position | Beginn |
|---|---|---|
SiteOne Therapeutics, Inc.
 SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Gründer | 01.01.2010 |
Airmid, Inc.
 Airmid, Inc. Pharmaceuticals: MajorHealth Technology Airmid, Inc. manufactures pharmaceutical products. The CEO of the American company is George Miljanich. | Vorstandsvorsitzender | - |
Ausbildung von George Miljanich
| University of California, Berkeley | Undergraduate Degree |
| University of California, Santa Cruz | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
SiteOne Therapeutics, Inc.
SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Health Technology |
Airmid, Inc.
Airmid, Inc. Pharmaceuticals: MajorHealth Technology Airmid, Inc. manufactures pharmaceutical products. The CEO of the American company is George Miljanich. | Health Technology |
